A phase 1 study of neoadjuvant chemotherapy followed by concurrent chemoradiation with gemcitabine, sorafenib, and vorinostat in pancreatic cancer.

被引：6

作者：

Poklepovic, Andrew Stewart ^{[1
]}

Fields, Emma Charlotte ^{[1
]}

Bandyopadhyay, Dipankar ^{[1
]}

Tombes, Mary Beth ^{[1
]}

Kmieciak, Maciej ^{[1
]}

McGuire, William P. ^{[1
]}

Gordon, Sarah W. ^{[1
]}

Kaplan, Brian J. ^{[1
]}

Myers, Jennifer Lynn ^{[1
]}

Matin, Khalid ^{[1
]}

Patel, Bhaumik ^{[1
]}

Kothadia, Sejal ^{[1
]}

Dent, Paul ^{[1
]}

机构：

[1] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期

关键词：

D O I：

10.1200/JCO.2021.39.15_suppl.e16268

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e16268

引用

下载

页数：3

共 50 条

[1] A phase 1 study of neoadjuvant chemotherapy with gemcitabine plus nab-paclitaxel, followed by concurrent chemoradiation with gemcitabine, sorafenib, and vorinostat in locally advanced pancreatic cancer
Park, Haeseong
Poklepovic, Andrew
CANCER RESEARCH, 2014, 74 (19)
[2] Neoadjuvant chemotherapy with gemcitabine and cisplatin followed by chemoradiation in locally aadvanced cervical cancer.
Mateen, Abdul
Adil, Allah Rakha
Khan, Muhammad Saqib
Maken, Rab Nawaz
Hashmi, Quratul Ain
Duraishi, Arif Moin
Abdullah, Famya
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[3] Neoadjuvant chemotherapy followed by concomitant chemoradiation with gemcitabine in muscle invasive bladder cancer.
Mateen, Abdul
Adil, Allah Rakha
Ml, Quratul Ain Hash
Duraishi, Arif Moin
Abdullah, Famya
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[4] Phase II trial of postoperative adjuvant gemcitabine and cisplatin chemotherapy followed by chemoradiation with gemcitabine in patients with resected pancreatic cancer.
Kwon, J. H.
Chie, E. K.
Kim, J. H.
Im, S.
Oh, D.
Kim, Y.
Han, S.
Lee, K.
Jang, J.
Kim, T.
Kim, J. S.
Han, H. S.
Kim, S.
Yoon, Y. B.
Bang, Y.
Ha, S. W.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[5] Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation Therapy for Oesophageal Cancer Patients
Maung, Maung Kyaw
ANNALS OF ONCOLOGY, 2019, 30
[6] Neoadjuvant Chemotherapy With Cisplatin and Gemcitabine Followed by Chemoradiation Versus Chemoradiation for Locally Advanced Cervical Cancer: A Randomized Phase II Trial
da Costa, Samantha Cabral S.
Bonadio, Renata Colombo
Gabrielli, Flavia Carolina G.
Aranha, Andrea S.
Dias Genta, Maria Luiza N.
Miranda, Vanessa C.
de Freitas, Daniela
Abdo Filho, Elias
Ferreira, Patricia A. O.
Machado, Karime K.
Scaranti, Mariana
Carvalho, Heloisa de A.
Estevez-Diz, Maria Del Pilar
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (33) : 3124 - +
[7] Locally advanced cervical cancer - neoadjuvant chemotherapy followed by concurrent chemoradiation and targeted therapy as maintenance: A phase II study
Benson, Rony
Pathy, Sushmita
Kumar, Lalit
Mathur, Sandeep
Dadhwal, Vatsla
Mohanti, Bidhu Kalyan
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2019, 15 (06) : 1359 - 1364
[8] Phase 1b study of concurrent administration of marimastat and gemcitabine in nonresectable pancreatic cancer.
White, JD
Carmichael, J
Woll, PJ
Guilford, T
Russell, RC
BRITISH JOURNAL OF CANCER, 1998, 78 : 30 - 30
[9] Phase II study of induction chemotherapy with fixed dose rate (FDR) gemcitabine and cisplatin followed by concurrent chemoradiation with capecitabine for locally advanced pancreatic cancer (LAPC)
Kim, J.
Im, S.
Park, H.
Chie, E.
Hwang, J.
Kim, J.
Kim, T.
Bang, Y.
Ha, S.
Yoon, Y.
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
[10] A phase II study of induction chemotherapy with gemcitabine plus S-1 (GS) followed by chemoradiation for locally advanced pancreatic cancer (LAPC)
Nakachi, K.
Furuse, J.
Kinoshita, T.
Kawashima, M.
Ishii, H.
Suzuki, E.
Shimizu, S.
Yoshino, M.
EJC SUPPLEMENTS, 2007, 5 (04): : 270 - 270

← 1 2 3 4 5 →